AXP
67
4
CTAS
59
-5
EBAY
45
2
GD
57
-2
UNH
42
4
RF
54
4
BBY
51
2
HPE
59
2
AES
47
-8
ADBE
70
2
ZION
53
3
HBAN
48
4
MNST
61
-2
V
56
-2
HCA
46
-13
GT
37
3
UAL
50
6
VNO
56
4
IVZ
52
2
CAH
41
-2
AXP
67
4
CTAS
59
-5
EBAY
45
2
GD
57
-2
UNH
42
4
RF
54
4
BBY
51
2
HPE
59
2
AES
47
-8
ADBE
70
2
ZION
53
3
HBAN
48
4
MNST
61
-2
V
56
-2
HCA
46
-13
GT
37
3
UAL
50
6
VNO
56
4
IVZ
52
2
CAH
41
-2
Financhill
Back

NovoCure Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison

Sell
29

NVCR
NovoCure

Last Price:
17.15
Seasonality Move:
10.33%
Buy
55

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
45.13
Seasonality Move:
-11.02%
Sell
29
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $17.11. The Score for NVCR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP) is a Buy

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $45.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $17.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight selling pressure.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $45.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 32.44 Sell
Chaikin Money Flow: -2048068 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.95 - 22.75) Sell
Bollinger Bands (100): (13.24 - 20.16) Buy

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 51.62 Buy
Chaikin Money Flow: 1520753 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.2 - 48.24) Buy
Bollinger Bands (100): (31.14 - 46.02) Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.42 Sell
20-day SMA: 20.46 Sell
50-day SMA: 18.54 Sell
200-day SMA: 15.41 Buy
8-day EMA: 18.43 Sell
20-day EMA: 19.52 Sell
50-day EMA: 18.85 Sell
200-day EMA: 21.61 Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.66 Buy
20-day SMA: 45.82 Sell
50-day SMA: 42.78 Buy
200-day SMA: 22.9 Buy
8-day EMA: 44.51 Buy
20-day EMA: 44.85 Buy
50-day EMA: 42.76 Buy
200-day EMA: 28.27 Buy

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.70 per share, an increase next quarter of $0.13 per share, an increase this year of $5.96 per share, and an increase next year of $0.18 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):